198 related articles for article (PubMed ID: 23060304)
21. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
22. Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker.
Martignoni G; Brunelli M; Segala D; Munari E; Gobbo S; Cima L; Borze I; Wirtanen T; Sarhadi VK; Atanesyan L; Savola S; Barzon L; Masi G; Fassan M; Eble JN; Bohling T; Cheng L; Delahunt B; Knuutila S
Pathology; 2017 Jan; 49(1):10-18. PubMed ID: 27923499
[TBL] [Abstract][Full Text] [Related]
23. Clear cell tubulopapillary renal cell carcinoma: a study of 36 distinctive low-grade epithelial tumors of the kidney.
Aydin H; Chen L; Cheng L; Vaziri S; He H; Ganapathi R; Delahunt B; Magi-Galluzzi C; Zhou M
Am J Surg Pathol; 2010 Nov; 34(11):1608-21. PubMed ID: 20924276
[TBL] [Abstract][Full Text] [Related]
24. The usefulness of immunohistochemical markers in the differential diagnosis of renal neoplasms.
Zhou M; Roma A; Magi-Galluzzi C
Clin Lab Med; 2005 Jun; 25(2):247-57. PubMed ID: 15848735
[TBL] [Abstract][Full Text] [Related]
25. A case of oncocytic papillary renal cell carcinoma.
Okada A; Sasaki S; Fujiyoshi Y; Niimi K; Kurokawa S; Umemoto Y; Kohri K
Int J Urol; 2009 Sep; 16(9):765-7. PubMed ID: 19769658
[TBL] [Abstract][Full Text] [Related]
26. Papillary cystadenoma of the epididymis and broad ligament: morphologic and immunohistochemical overlap with clear cell papillary renal cell carcinoma.
Cox R; Vang R; Epstein JI
Am J Surg Pathol; 2014 May; 38(5):713-8. PubMed ID: 24441657
[TBL] [Abstract][Full Text] [Related]
27. Clear cell papillary renal cell carcinoma: Incidence, morphological features, immunohistochemical profile, and biologic behavior: A single institution study.
Alexiev BA; Drachenberg CB
Pathol Res Pract; 2014 Apr; 210(4):234-41. PubMed ID: 24485757
[TBL] [Abstract][Full Text] [Related]
28. Clear cell papillary renal cell carcinoma with angiomyomatous stroma: a histological, immunohistochemical, and fluorescence in situ hybridization study.
Alexiev BA; Thomas C; Zou YS
Virchows Arch; 2014 Jun; 464(6):709-16. PubMed ID: 24771120
[TBL] [Abstract][Full Text] [Related]
29. Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue.
Zigeuner R; Ratschek M; Rehak P; Schips L; Langner C
Urology; 2004 Apr; 63(4):651-5. PubMed ID: 15072872
[TBL] [Abstract][Full Text] [Related]
30. Clear cell papillary renal cell carcinoma is the fourth most common histologic type of renal cell carcinoma in 290 consecutive nephrectomies for renal cell carcinoma.
Zhou H; Zheng S; Truong LD; Ro JY; Ayala AG; Shen SS
Hum Pathol; 2014 Jan; 45(1):59-64. PubMed ID: 24182559
[TBL] [Abstract][Full Text] [Related]
31. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
32. Application of Chromosome Microarray Analysis for the Differential Diagnosis of Low-grade Renal Cell Carcinoma With Clear Cell and Papillary Features.
Pei J; Al-Saleem T; Uzzo RG; Dulaimi E; Testa JR; Wei S
Appl Immunohistochem Mol Morphol; 2020 Feb; 28(2):123-129. PubMed ID: 32044880
[TBL] [Abstract][Full Text] [Related]
33. Clear cell papillary renal cell carcinoma in patients with von Hippel-Lindau syndrome--clinicopathological features and comparative genomic analysis of 3 cases.
Rao P; Monzon F; Jonasch E; Matin SF; Tamboli P
Hum Pathol; 2014 Sep; 45(9):1966-72. PubMed ID: 25081542
[TBL] [Abstract][Full Text] [Related]
34. Alpha-methylacyl-CoA racemase as a marker in the differential diagnosis of metanephric adenoma.
Olgac S; Hutchinson B; Tickoo SK; Reuter VE
Mod Pathol; 2006 Feb; 19(2):218-24. PubMed ID: 16424894
[TBL] [Abstract][Full Text] [Related]
35. A panel of immunohistochemical stains assists in the distinction between ovarian and renal clear cell carcinoma.
Cameron RI; Ashe P; O'Rourke DM; Foster H; McCluggage WG
Int J Gynecol Pathol; 2003 Jul; 22(3):272-6. PubMed ID: 12819395
[TBL] [Abstract][Full Text] [Related]
36. Reactivity of CK7 across the spectrum of renal cell carcinomas with clear cells.
Gonzalez ML; Alaghehbandan R; Pivovarcikova K; Michalova K; Rogala J; Martinek P; Foix MP; Mundo EC; Comperat E; Ulamec M; Hora M; Michal M; Hes O
Histopathology; 2019 Mar; 74(4):608-617. PubMed ID: 30444288
[TBL] [Abstract][Full Text] [Related]
37. Clear cell papillary renal cell carcinoma: a clinicopathologic analysis of 6 cases.
Yan WX; Cao WR; Zhao J; Zhang W; Wang XL; Yuan Q; Dang SQ
Int J Clin Exp Pathol; 2015; 8(5):4595-9. PubMed ID: 26191150
[TBL] [Abstract][Full Text] [Related]
38. The diagnostic utility of MOC31, BerEP4, RCC marker and CD10 in the classification of renal cell carcinoma and renal oncocytoma: an immunohistochemical analysis of 328 cases.
Pan CC; Chen PC; Ho DM
Histopathology; 2004 Nov; 45(5):452-9. PubMed ID: 15500648
[TBL] [Abstract][Full Text] [Related]
39. Differential diagnosis of renal tumors with papillary architecture.
Tickoo SK; Reuter VE
Adv Anat Pathol; 2011 Mar; 18(2):120-32. PubMed ID: 21326010
[TBL] [Abstract][Full Text] [Related]
40. Genetic mutations in accordance with a low malignant potential tumour are not demonstrated in clear cell papillary renal cell carcinoma.
Raspollini MR; Castiglione F; Cheng L; Montironi R; Lopez-Beltran A
J Clin Pathol; 2016 Jun; 69(6):547-50. PubMed ID: 26941183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
